醫療季營收分析

最後更新 2026-09-12 21:20:32 (EDT)

醫療季營收趨勢分析

判斷醫療類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療類股調整後季營收與 XLV ETF走勢圖

FindBillion.com

季節調整後季營收成長率


季營收季增率	2.4%
季營收年增率	6.4%

醫療季營收與股價相關性分析

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療類股整體季節調整後季營收-股價散佈圖

醫療類股整體季節調整後季營收與股價高度相關，相關性越高，參考意義越大。

醫療類股整體季節調整後季營收與股價間的
決定係數

高度相關 0.86

FindBillion.com

醫療相關個股

醫療相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。

代碼	公司名稱	季營收季增率	季營收年增率
ARWR	Arrowhead Pharmaceuticals, Inc.	120.7%	171%
KYMR	Kymera Therapeutics, Inc.	81.9%	466.4%
ASND	Ascendis Pharma A/S	72.9%	118.2%
HLN	Haleon plc	48.6%	106%
INSM	Insmed Incorporated	48.6%	296.1%
CORT	Corcept Therapeutics Incorporated	47.1%	31.7%
IONS	Ionis Pharmaceuticals, Inc.	31.4%	71%
BMRN	BioMarin Pharmaceutical Inc.	31.3%	19.9%
TGTX	TG Therapeutics, Inc.	22.8%	70.3%
GKOS	Glaukos Corporation	22.6%	49.5%
INCY	Incyte Corporation	19.8%	37.7%
WAT	Waters Corporation	17.9%	113.3%
VRTX	Vertex Pharmaceuticals Incorporated	16.1%	12.5%
AXSM	Axsome Therapeutics, Inc.	15.3%	45.5%
RPRX	Royalty Pharma plc	14.6%	16.5%
ABT	Abbott Laboratories	13.2%	13%
HALO	Halozyme Therapeutics, Inc.	12.4%	47.7%
TEM	Tempus AI, Inc.	12.1%	21.6%
BMY	Bristol-Myers Squibb Company	11.8%	5.7%
LLY	Eli Lilly and Company	11.3%	47.7%
IBRX	ImmunityBio, Inc.	11.2%	93.9%
SYK	Stryker Corporation	10.9%	9.4%
NTRA	Natera, Inc.	10.8%	37.7%
TMO	Thermo Fisher Scientific Inc.	10.2%	10.5%
VTRS	Viatris Inc.	9.7%	4.9%
LH	Labcorp Holdings Inc.	9.5%	5.8%
ALC	Alcon Inc.	9.4%	8.7%
GILD	Gilead Sciences, Inc.	9.1%	10.2%
AMGN	Amgen Inc.	9%	9.7%
MDGL	Madrigal Pharmaceuticals, Inc.	8.9%	71.2%
OSCR	Oscar Health, Inc.	8.9%	70.4%
BIO	Bio-Rad Laboratories, Inc.	8.7%	-0.1%
EXEL	Exelixis, Inc.	8.7%	10.6%
HCA	HCA Healthcare, Inc.	8.3%	8.7%
THC	Tenet Healthcare Corporation	8.2%	6.8%
BDX	Becton, Dickinson and Company	8.2%	-9.5%
SNY	Sanofi	7.9%	14.6%
PHG	Koninklijke Philips N.V.	7.7%	0.5%
MCK	McKesson Corporation	7.6%	7.7%
IQV	IQVIA Holdings Inc.	7.2%	8.7%
EW	Edwards Lifesciences Corporation	7.1%	13.6%
CI	Cigna Corporation	7%	6.6%
GH	Guardant Health, Inc.	6.5%	44.3%
SOLV	Solventum Corporation	6.5%	2.2%
BTSG	BrightSpring Health Services, Inc. Common Stock	6.3%	23%
DGX	Quest Diagnostics Incorporated	6.2%	10.2%
ALNY	Alnylam Pharmaceuticals, Inc.	6.1%	66.9%
ICLR	ICON Public Limited Company	5.8%	2.3%
PEN	Penumbra, Inc.	5.8%	14.9%
HUM	Humana Inc.	5.7%	26.2%
COR	Cencora, Inc.	5.7%	5.1%
BAX	Baxter International Inc.	5.5%	5.3%
ZTS	Zoetis Inc.	5.4%	0.3%
ILMN	Illumina, Inc.	5.3%	9.7%
BNTX	BioNTech SE	5.3%	-58.8%
FMS	Fresenius Medical Care AG & Co. KGaA	5.2%	3.1%
AVTR	Avantor, Inc.	5.2%	0.5%
HSIC	Henry Schein, Inc.	5.1%	6.7%
ZBH	Zimmer Biomet Holdings, Inc.	5.1%	4.8%
REGN	Regeneron Pharmaceuticals, Inc.	5%	16.7%
ABBV	AbbVie Inc.	5%	10.2%
GMED	Globus Medical, Inc.	4.9%	5.9%
CVS	CVS Health Corp.	4.9%	7.3%
JAZZ	Jazz Pharmaceuticals plc	4.9%	15.5%
CYTK	Cytokinetics, Incorporated	4.6%	-57.1%
ENSG	The Ensign Group, Inc.	4.6%	17.3%
QGEN	Qiagen N.V.	4.5%	0.3%
BIIB	Biogen Inc.	4.5%	3.4%
ONC	BeOne Medicines AG	4.3%	29.6%
MDT	Medtronic plc	3.9%	13.7%
ISRG	Intuitive Surgical, Inc.	3.7%	18.5%
MRK	Merck & Co., Inc.	3.6%	5.1%
RGEN	Repligen Corporation	3.6%	11.9%
BSX	Boston Scientific Corporation	3.4%	7.5%
UHS	Universal Health Services, Inc.	3.4%	8.3%
KRYS	Krystal Biotech, Inc.	3.3%	24.1%
ELAN	Elanco Animal Health Incorporated	3.2%	10.2%
PODD	Insulet Corp.	3.1%	23.5%
NVS	Novartis AG	3%	-2.8%
TECH	Bio-Techne Corporation	3%	1.3%
IDXX	IDEXX Laboratories, Inc.	2.8%	9.7%
TEVA	Teva Pharmaceutical Industries Limited	2.6%	-0.8%
STE	STERIS plc	2.5%	7.3%
ALGN	Align Technology, Inc.	2.4%	4.3%
UNH	UnitedHealth Group Incorporated	2.2%	0.4%
MEDP	Medpace Holdings, Inc.	2%	17.2%
EHC	Encompass Health Corporation	2%	9.6%
A	Agilent Technologies, Inc.	1.8%	8.1%
CAH	Cardinal Health, Inc.	1.7%	6.1%
MTD	Mettler-Toledo International Inc.	1.4%	4.5%
CRL	Charles River Laboratories International, Inc.	1.2%	-2.7%
ELV	Elevance Health Inc.	1.1%	1.4%
NBIX	Neurocrine Biosciences, Inc.	0.9%	39.5%
MOH	Molina Healthcare, Inc.	0.8%	-4.8%
TAK	Takeda Pharmaceutical Company Limited	0.4%	10.2%
DVA	DaVita Inc.	0.4%	5.2%
PFE	Pfizer Inc.	0.3%	2.6%
GSK	GSK plc	0.2%	-1.1%
GEHC	GE HealthCare Technologies Inc.	0.2%	5.8%
JNJ	Johnson & Johnson	0.2%	3%
DXCM	DexCom, Inc.	0.2%	13.1%
RMD	ResMed Inc.	0.1%	8.6%
WST	West Pharmaceutical Services, Inc.	-0.6%	13.8%
DHR	Danaher Corporation	-0.9%	5.5%
RVTY	Revvity, Inc.	-3.8%	1.3%
COO	The Cooper Companies, Inc.	-4.7%	0.6%
AZN	AstraZeneca PLC	-5.5%	5.1%
UTHR	United Therapeutics Corporation	-6.1%	-1.9%
SNN	Smith & Nephew plc	-6.9%	9.6%
CNC	Centene Corp.	-9%	-9%
ROIV	Roivant Sciences Ltd.	-10.8%	-33.5%
NVO	Novo Nordisk A/S	-16%	2.1%
TXG	10x Genomics, Inc.	-16.3%	-17.9%
BBIO	BridgeBio Pharma, Inc.	-19.9%	88.6%
GMAB	Genmab A/S	-25%	24.9%
ARGX	argenx SE	-34.5%	12.5%
RDY	Dr. Reddy's Laboratories Limited	-41.7%	-5%
MRNA	Moderna, Inc.	-65.1%	2.1%
PTGX	Protagonist Therapeutics, Inc.	-100%	-100%
APGE	Apogee Therapeutics, Inc.	-	-
RVMD	Revolution Medicines, Inc.	-	-
PCVX	Vaxcyte, Inc.	-	-
ABVX	Abivax S.A.	-	-100%
PRAX	Praxis Precision Medicines, Inc.	-	-
SMMT	Summit Therapeutics Inc.	-	-
MDLN	Medline Inc.	-	-

警語

1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整，需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

醫療類股

醫療季營收趨勢分析

判斷 醫療 類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療季營收與股價相關性分析

判斷 醫療 類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股

醫療 相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。

判斷醫療類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。